Steve Cohen: portfolio of Point72 Asset Management
Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.
Source: 13F filing with the US Securities and Exchange Commission dated May 16, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q1 2022. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 22.3B USD
- Positions
- 1,002
- Share of the ten largest
- 11.2%
The ten largest positions Q1 2022
- Booking Holdings 1.6%▲ +47.1%
- Merck & Co. 1.3%▲ +6,768.8%
- Amazon 1.3%▼ −31.4%
- Argenx SE 1.1%▲ +96.1%
- FedEx 1.1%▲ +138.2%
- Analog Devices 1.1%▲ +362.6%
- Arista Networks 1.0%▲ +29.4%
- Visa Inc. 0.9%▲ +295.9%
- S&P Global 0.9%▲ +142.2%
- Seagen Inc 0.9%▲ +119.5%
Show all positions of this quarter
Choose a quarter (50 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
All positions Q1 2022
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| Bunge Limited | 0.2% | 377,322 | 41.8M USD | +24.3% increased | Q2 2014 or earlier 32 quarters |
| CME CME Group | < 0.1% | 66,243 | 15.8M USD | +10.3% increased | Q2 2014 or earlier 32 quarters |
| BKNG Booking Holdings | 1.6% | 151,303 | 355.3M USD | +47.1% increased | Q1 2018 17 quarters |
| PANW Palo Alto Networks | 0.5% | 166,550 | 103.7M USD | +213.6% increased | Q1 2018 17 quarters |
| Repligen Corp | 0.1% | 155,882 | 29.3M USD | +38.3% increased | Q3 2018 15 quarters |
| LVS Las Vegas Sands | 0.1% | 600,386 | 23.3M USD | +182.9% increased | Q3 2018 15 quarters |
| Enerplus Corp | < 0.1% | 1,525,900 | 19.4M USD | +247.6% increased | Q4 2018 14 quarters |
| FIS Fidelity National Information Services | 0.7% | 1,468,100 | 147.4M USD | +81.4% increased | Q1 2019 13 quarters |
| Select Sector SPDR TR | 0.5% | 1,405,036 | 107.4M USD | +214.0% increased | Q1 2019 13 quarters |
| Arvinas Inc | 0.3% | 857,727 | 57.7M USD | +33.8% increased | Q1 2019 13 quarters |
| Childrens Pl Inc New | < 0.1% | 116,094 | 5.7M USD | +486.3% increased | Q1 2019 13 quarters |
| JBL Jabil | 0.8% | 3,020,700 | 186.5M USD | +3.7% increased | Q2 2019 12 quarters |
| DELL Dell Technologies | 0.4% | 1,603,000 | 80.5M USD | +172.2% increased | Q2 2019 12 quarters |
| Cytokinetics Inc | 0.3% | 1,622,600 | 59.7M USD | +83.3% increased | Q2 2019 12 quarters |
| Akero Therapeutics Inc | 0.1% | 1,847,000 | 26.2M USD | +5.0% increased | Q2 2019 12 quarters |
| Ideaya Biosciences Inc | < 0.1% | 1,847,017 | 20.7M USD | +36.8% increased | Q2 2019 12 quarters |
| PG Procter & Gamble | < 0.1% | 114,336 | 17.5M USD | +1.7% increased | Q2 2019 12 quarters |
| Bicycle Therapeutics PLC | 0.3% | 1,619,802 | 71.1M USD | +3.0% increased | Q4 2019 10 quarters |
| Neoleukin Therapeutics Inc | < 0.1% | 1,225,000 | 2.3M USD | +21.2% increased | Q4 2019 10 quarters |
| Exelixis Inc | 0.7% | 6,854,300 | 155.4M USD | +62.3% increased | Q1 2020 9 quarters |
| Texas Roadhouse Inc | 0.3% | 805,344 | 67.4M USD | +273.8% increased | Q1 2020 9 quarters |
| DHR Danaher Corporation | 0.1% | 102,782 | 30.1M USD | +47.3% increased | Q1 2020 9 quarters |
| Applied Therapeutics Inc | < 0.1% | 2,549,000 | 5.4M USD | +128.8% increased | Q1 2020 9 quarters |
| MRK Merck & Co. | 1.3% | 3,582,000 | 293.9M USD | +6,768.8% increased | Q2 2020 8 quarters |
| ADI Analog Devices | 1.1% | 1,427,061 | 235.7M USD | +362.6% increased | Q2 2020 8 quarters |
| TMUS T-Mobile US | 0.8% | 1,317,809 | 169.1M USD | +43.0% increased | Q2 2020 8 quarters |
| Cenovus Energy Inc | 0.7% | 9,261,681 | 154.5M USD | +495.4% increased | Q2 2020 8 quarters |
| HUM Humana | 0.5% | 258,200 | 112.4M USD | +3,588.6% increased | Q2 2020 8 quarters |
| Uniqure NV | 0.3% | 3,250,300 | 58.7M USD | +65.4% increased | Q2 2020 8 quarters |
| Switch Inc | 0.2% | 1,604,201 | 49.4M USD | +652.8% increased | Q2 2020 8 quarters |
| Relmada Therapeutics Inc | 0.2% | 1,312,400 | 35.4M USD | +38.7% increased | Q2 2020 8 quarters |
| Crinetics Pharmaceuticals In | 0.1% | 1,206,338 | 26.5M USD | +9.2% increased | Q2 2020 8 quarters |
| Laboratory Corp Amer HLDGS | 0.1% | 92,072 | 24.3M USD | +28.6% increased | Q2 2020 8 quarters |
| Radnet Inc | < 0.1% | 465,300 | 10.4M USD | +24.1% increased | Q2 2020 8 quarters |
| E L F Beauty Inc | < 0.1% | 148,401 | 3.8M USD | +374.1% increased | Q2 2020 8 quarters |
| SPDR Ser TR | < 0.1% | 35,000 | 2.2M USD | +133.3% increased | Q2 2020 8 quarters |
| V Visa Inc. | 0.9% | 927,069 | 205.6M USD | +295.9% increased | Q3 2020 7 quarters |
| COP ConocoPhillips | 0.9% | 1,981,134 | 198.1M USD | +230.0% increased | Q3 2020 7 quarters |
| Capri Holdings Limited | 0.4% | 1,793,780 | 92.2M USD | +136.4% increased | Q3 2020 7 quarters |
| CSX CSX Corporation | 0.3% | 1,978,627 | 74.1M USD | +25.2% increased | Q3 2020 7 quarters |
| MAT Mattel | 0.3% | 2,597,911 | 57.7M USD | +100.3% increased | Q3 2020 7 quarters |
| AMD Advanced Micro Devices | 0.2% | 344,980 | 37.7M USD | +60.7% increased | Q3 2020 7 quarters |
| ELV Elevance Health | 0.1% | 61,151 | 30.0M USD | +39.9% increased | Q3 2020 7 quarters |
| ASML ASML Holding (ADR) | 0.1% | 41,500 | 27.7M USD | +548.4% increased | Q3 2020 7 quarters |
| Morphic Hldg Inc | 0.1% | 617,434 | 24.8M USD | +35.3% increased | Q3 2020 7 quarters |
| SHIFT4 Pmts Inc | 0.1% | 399,800 | 24.8M USD | +88.3% increased | Q3 2020 7 quarters |
| CRL Charles River Laboratories | 0.1% | 78,661 | 22.3M USD | +2.3% increased | Q3 2020 7 quarters |
| Transalta Corp | < 0.1% | 1,064,100 | 11.0M USD | +117.3% increased | Q3 2020 7 quarters |
| Syndax Pharmaceuticals Inc | < 0.1% | 360,000 | 6.3M USD | +2.0% increased | Q3 2020 7 quarters |
| ZTS Zoetis | 0.6% | 665,754 | 125.6M USD | +363.8% increased | Q4 2020 6 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 longest-held of 280 positions.
Plus 106 option positions, value of the underlying shares as reported 2.6B USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- SPDR S&P 500 ETF TR Put 579.2M USD
- Merck & Co. Call 188.3M USD
- Invesco QQQ TR Put 149.0M USD
- Apple Inc. Put 111.3M USD
- Ishares TR Call 102.6M USD
- Alibaba Group (ADR) Call 99.6M USD
- Select Sector SPDR TR Call 95.9M USD
- ExxonMobil Call 82.6M USD
- Ishares TR Put 74.3M USD
- Invesco Db Multi-Sector Comm Call 65.8M USD
Plus 30 positions in convertible bonds and bonds worth 303.2M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Dish Network Corporation principal 27.0M USD 26.2M USD
- Lumentum HLDGS Inc principal 20.0M USD 23.3M USD
- Sarepta Therapeutics Inc principal 17.0M USD 22.4M USD
- Spotify USA Inc principal 25.0M USD 21.3M USD
- American Airlines Group Inc principal 13.0M USD 17.9M USD
- Ford Mtr Co Del principal 15.0M USD 17.8M USD
- Docusign Inc principal 17.5M USD 16.4M USD
- Sea Ltd principal 18.9M USD 15.1M USD
- Sabre Glbl Inc principal 8.6M USD 14.2M USD
- Pinduoduo Inc principal 15.5M USD 13.7M USD
Breakdown by sector
- Technology 11.9%
- Health Care 6.7%
- Consumer Discretionary 6.3%
- Industrials 5.7%
- Financials 5.2%
- Energy 3.1%
- Consumer Staples 2.9%
- Utilities 2.8%
- Communication Services 2.7%
- Real Estate 1.6%
- Materials 1.3%
- not in our coverage 50.0%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors